Replimune Group (REPL) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

REPL is expected to report earnings to rise 7.05% to -83 cents per share on November 05

Replimune Group REPL Stock Earnings Reports

Q3'24

Est.

$-0.83

Q2'24

Beat

by $0.08

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.12

Q3'23

Missed

by $0.09

The last earnings report on August 08 showed earnings per share of -77 cents, beating the estimate of -85 cents. With 432.17K shares outstanding, the current market capitalization sits at 731.72M.

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for REPL (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com